Company news

Erasca, Inc. news in 2025

Erasca, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Erasca to Present at the 8th Annual Evercore Healthcare Conference

November 24, 2025

Erasca Reports Third Quarter 2025 Business Updates and Financial Results

November 11, 2025

Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015

November 5, 2025

Erasca to Present at Upcoming Conferences in November

November 3, 2025

Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

September 1, 2025

Erasca Reports Second Quarter 2025 Business Updates and Financial Results

August 11, 2025

Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001

June 1, 2025

Erasca to Present at Upcoming Investor Conferences in June

May 28, 2025

Erasca Reports First Quarter 2025 Business Updates and Financial Results

May 12, 2025

Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway

May 12, 2025

Erasca to Present at the Bank of America Securities Health Care Conference

May 6, 2025

Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting

April 28, 2025

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting

March 24, 2025

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results

March 19, 2025

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

January 30, 2025

Erasca to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 6, 2025

Decks in 2025